https://www.zacks.com/stock/news/2233369/abercrombie-fitch-anf-is-up-1-59-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2233369
Feb 28, 2024 - Does Abercrombie & Fitch (ANF) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-7900368387853775625
0
https://www.zacks.com/stock/news/2233360/deckers-deck-is-up-2-03-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2233360
Feb 28, 2024 - Does Deckers (DECK) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-7877571297095136894
0
https://www.cnbc.com/2024/02/29/pce-inflation-january-2023-.html
Feb 29, 2024 - The core PCE price index was expected to increase 0.4% in January on a monthly basis and 2.8% from a year ago.
0
cnbc:6467149747370699572
0
https://www.zacks.com/stock/news/2234081/meta-platforms-meta-is-up-2-26-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2234081
Feb 29, 2024 - Does Meta Platforms (META) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-1430084658046514534
0
https://www.zacks.com/stock/news/2233978/emcor-eme-q4-earnings-and-revenues-beat-estimates-stock-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2233978
Feb 29, 2024 - EMCOR's (EME) Q4 results portray solid contributions from its combined U.S. Construction segments and the U.S. Building Services on resilient end-market demand and execution initiatives.
zc:-8464067070000662849
0
https://www.zacks.com/stock/news/2234038/why-is-ups-ups-up-4-1-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2234038
Feb 29, 2024 - UPS (UPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
zc:-7771983460271990564
0
https://www.zacks.com/stock/news/2234137/sarepta-srpt-q4-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2234137
Feb 29, 2024 - Sarepta's (SRPT) Q4 earnings and sales beat estimates on the back of strong sales for recently-approved DMD gene therapy Elevidys.
zc:-2192800226062534333
0
https://www.zacks.com/stock/news/2234082/masco-mas-is-up-2-43-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2234082
Feb 29, 2024 - Does Masco (MAS) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-3974230539799900835
0
https://www.zacks.com/stock/news/2234026/why-is-nvr-nvr-up-7-2-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2234026
Feb 29, 2024 - NVR (NVR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
zc:6268514441943268647
0
https://www.rttnews.com/story.aspx?Id=3428157
Feb 28, 2024 - (Adds Outlook, stock movement)
0
rttnews:6072187401058336036
0